Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients
Conditions: Pediatric Patients Affected by Any Type of Severe Combined Immunodeficiency (SCID); Eligibility for Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Intervention: Genetic: Human T Lymphoid Progenitor (HTLP) injection Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials